Abstract
Presented herein are Synechococcus strains engineered to express the bacterial ethylene-forming enzyme (EFE) that exhibit unstable ethylene production due to toxicity and genomic instability induced by accumulation of the EFE-byproduct guanidine. Co-expression of EFE and Sll1077 significantly enhanced genomic stability and enabled the resulting Synechococcus strain GD-EFE7942 to achieve sustained high-level ethylene production. The engineered strains and methods disclosed herein are useful for guanidine degradation pathways and for ethylene bioproduction in cyanobacteria.
| Original language | American English |
|---|---|
| Patent number | 12,448,632 B2 |
| Filing date | 21/10/25 |
| State | Published - 2025 |
NLR Publication Number
- NREL/PT-2700-98200
Keywords
- ethylene-forming enzyme (EFE)
- genomic instability
- Synechococcus strains